Stereotaxis
Stereotaxis Inc., a US-based firm, innovates in medical robotics, enhancing electrophysiology outcomes with products like NIOBE® ES RMN System.
Founded
1990Stereotaxis Inc., a US-based firm, innovates in medical robotics, enhancing electrophysiology outcomes with products like NIOBE® ES RMN System.
Stereotaxis Inc., founded in St. Louis, MO, is a publicly traded American medical robotics company focused on enhancing clinical outcomes in electrophysiology. The company's core mission is to advance interventional medicine through innovative robotic technologies. Their flagship product, the NIOBE® ES Remote Magnetic Navigation (RMN) System, allows for precise and minimally invasive procedures, targeting small areas within the body for ablation, biopsy, and other interventions. Stereotaxis primarily serves healthcare professionals and patients seeking advanced treatment options.
Notable figures associated with Stereotaxis include its leadership team and key investors who have supported its growth and technological advancements. The company has achieved significant milestones, including widespread adoption of its RMN system in leading medical institutions globally. Stereotaxis' impact is evident in improved patient outcomes and the advancement of minimally invasive surgical techniques, solidifying its position as a pioneer in the field of medical robotics.
Companies similar to Stereotaxis include Medrobotics, PROCEPT BioRobotics, AiM Medical Robotics and SS Innovations.
Stereotaxis was founded in 1990.
Stereotaxis' headquarters is located in St. Louis, MO, US.
Stereotaxis' most recent funding round was for $25M (USD) in August 2019.
As of Aug 8, 2019, Stereotaxis has disclosed funding of $105M (USD). Undisclosed round amounts are excluded.
Stereotaxis has 130 employees as of Feb 6, 2024.
SS Innovations
